Bernstein keeps USD 3.55 target for Ambev stock

Published on 10/17/2026 at 19:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

In the first half of 2026, normalized EBITDA grew 9.60 percent. Ambev stock stood at USD 3.29 on October 16, 2026, up 0.92 percent versus prior close.

Analyst view and reporting date

Bernstein analyst Nadine Sarwat maintained a USD 3.55 target on October 15, 2026.
Normalized EBITDA grew 9.60 percent and normalized net income increased 10.10 percent in the first half of 2026.
Ambev stock stood at USD 3.29 at 4:00 p.m. ET on October 16, 2026, up 0.92 percent versus the prior close.
Ambev lists its third-quarter 2026 results for October 29, 2026.

ABEV, US02319V1035, Illustration mit AI erstellt.

According to Business Insider on October 15, 2026, Bernstein analyst Nadine Sarwat maintained a Hold rating and a USD 3.55 target for Ambev. That target lies 7.90 percent above the latest US quote. The latest NYSE quote stood at USD 3.29 on October 16, 2026 at 4:00 p.m. ET, up 0.92 percent versus the prior close.

First-half earnings set the backdrop

The July 30, 2026 earnings transcript on Yahoo Finance records normalized EBITDA growth of 9.60 percent and normalized net income growth of 10.10 percent in the first half of 2026. In the second quarter alone, normalized EBITDA reached BRL 6.40 billion, up 8.90 percent, while the normalized EBITDA margin expanded by 0.80 percentage points.

Range and trading activity

The NYSE listing had a 52-week range of USD 2.18 to USD 3.45 as of October 16, 2026. The latest quote was 4.64 percent below the high and 51.05 percent above the low. Trading volume reached 23,495,006 shares against an average of 27,510,782 shares.

Valuation and results date

Ambev's market capitalization was USD 51.0 billion and its price-to-earnings ratio was 16.19 as of October 16, 2026. The investor-relations calendar lists third-quarter 2026 results for October 29, 2026, before the opening of the B3 and NYSE, according to Ambev.

Comparison with peers

Ambev (NYSE, USD): plus 0.92 percent, P/E 16.19, market capitalization USD 51.0 billion.
Anheuser-Busch InBev (NYSE, USD): plus 1.61 percent, P/E 13.97, market capitalization USD 162.6 billion.
Molson Coors Beverage (NYSE, USD): plus 1.26 percent, P/E minus 3.42, market capitalization USD 7.4 billion.

Latest quote and investor calendar

The latest NYSE quote stood at USD 3.29 on October 16, 2026 at 4:00 p.m. ET, up 0.92 percent versus the prior close. The 52-week high was USD 3.45, leaving the stock 4.64 percent below that level. The next scheduled company date is October 29, 2026, when Ambev plans to release third-quarter results before the opening of the B3 and NYSE.